| scholarly article | Q13442814 |
| P50 | author | Clara Menéndez | Q58876158 |
| María Rupérez | Q88614899 | ||
| Marc Noguera-Julian | Q41071404 | ||
| P2093 | author name string | Roger Paredes | |
| Anifa Vala | |||
| Esperança Sevene | |||
| Raquel González | |||
| Cristina Rodríguez | |||
| Rocío Bellido | |||
| Sonia Maculuve | |||
| P2860 | cites work | Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection | Q24235500 |
| Prevalence of HIV-1 drug resistance among women screening for HIV prevention trials in KwaZulu-Natal, South Africa (MTN-009) | Q28486101 | ||
| Understanding the timing of HIV transmission from mother to infant | Q73437340 | ||
| Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. Bangkok Collaborative Perinatal HIV Transmission Study Group | Q77310339 | ||
| Recommendations for surveillance of transmitted HIV drug resistance in countries scaling up antiretroviral treatment | Q81511468 | ||
| Evolution of primary HIV drug resistance in a subtype C dominated epidemic in Mozambique | Q28535000 | ||
| Intermittent preventive treatment of malaria in pregnancy with mefloquine in HIV-infected women receiving cotrimoxazole prophylaxis: a multicenter randomized placebo-controlled trial | Q28543154 | ||
| Trends in Prevalence of HIV-1 Drug Resistance in a Public Clinic in Maputo, Mozambique | Q28546341 | ||
| HIV Incidence and Spatial Clustering in a Rural Area of Southern Mozambique | Q28647478 | ||
| Deep sequencing for HIV-1 clinical management | Q30241725 | ||
| Effect of HIV infection on pregnancy-related mortality in sub-Saharan Africa: secondary analyses of pooled community-based data from the network for Analysing Longitudinal Population-based HIV/AIDS data on Africa (ALPHA). | Q30627882 | ||
| Transmission of nevirapine-resistant HIV type 1 via breast milk to infants after single-dose nevirapine in Beira, Mozambique | Q34048188 | ||
| Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated | Q34424673 | ||
| HIV-1 drug resistance in recently HIV-infected pregnant mother's naïve to antiretroviral therapy in Dodoma urban, Tanzania | Q34993070 | ||
| Prevalence of transmitted HIV drug resistance among newly diagnosed antiretroviral therapy-naive pregnant women in Lilongwe and Blantyre, Malawi | Q35917559 | ||
| A Public Health Paradox: The Women Most Vulnerable to Malaria Are the Least Protected | Q36006670 | ||
| Pharmacokinetic interactions between artesunate-mefloquine and ritonavir-boosted lopinavir in healthy Thai adults | Q36144257 | ||
| Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults | Q36300127 | ||
| Surveillance of HIV drug resistance in children receiving antiretroviral therapy: a pilot study of the World Health Organization's generic protocol in Maputo, Mozambique. | Q36611206 | ||
| Impact of antiretroviral drugs in pregnant women and their children in Africa: HIV resistance and treatment outcomes | Q36852619 | ||
| Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global collaborative study and meta-regression analysis | Q37216235 | ||
| Low-frequency nevirapine (NVP)-resistant HIV-1 variants are not associated with failure of antiretroviral therapy in women without prior exposure to single-dose NVP. | Q37582339 | ||
| HIV and malaria interactions: where do we stand? | Q37984496 | ||
| Clinical pharmacokinetic drug interactions associated with artemisinin derivatives and HIV-antivirals. | Q38155450 | ||
| HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study | Q38869669 | ||
| Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. | Q38882753 | ||
| Rapid spread and genetic diversification of HIV type 1 subtype C in a rural area of southern Mozambique | Q39157020 | ||
| Determinants of virological failure and antiretroviral drug resistance in Mozambique | Q39414398 | ||
| Treatment options after virological failure of first-line tenofovir-based regimens in South Africa: an analysis by deep sequencing | Q40819283 | ||
| Risk of extended viral resistance in human immunodeficiency virus-1-infected Mozambican children after first-line treatment failure | Q43243977 | ||
| Maternal HIV-1 DNA load and mother-to-child transmission | Q44999905 | ||
| Profile: Manhiça Health Research Centre (Manhiça HDSS). | Q45090525 | ||
| Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections | Q45739329 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Mozambique | Q1029 |
| pregnant person | Q104720811 | ||
| P304 | page(s) | e0196451 | |
| P577 | publication date | 2018-05-09 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | HIV drug resistance patterns in pregnant women using next generation sequence in Mozambique | |
| P478 | volume | 13 |
| Q64968657 | A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance. | cites work | P2860 |
Search more.